Osteopore Ltd. (AU:OSX) has released an update.
Osteopore Ltd., an Australian-Singaporean regenerative medicine company, has announced the successful completion of pre-clinical studies for a novel 3D-printed bone implant in collaboration with the University of Chile. The implant, which has shown promise in speeding up bone regeneration, will be moving to clinical studies in the second half of 2025. This development cements Osteopore’s presence in the $68.9 million Latin American medical device market.
For further insights into AU:OSX stock, check out TipRanks’ Stock Analysis page.
